Lu Kai, Bhat Madhavi, Basu Sujit
Department of Pathology, Ohio State University, Columbus, OH, 43210, USA.
Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, 43210, USA.
Angiogenesis. 2016 Jul;19(3):287-95. doi: 10.1007/s10456-016-9512-y. Epub 2016 May 6.
Angiogenesis, or new blood vessel formation, is an important process in the pathogenesis of several diseases and thus has been targeted for the prevention and treatment for many disorders. However, the anti-angiogenic agents that are currently in use are mainly synthetic compounds and humanized monoclonal antibodies, which are either expensive or toxic, thereby limiting their use in many patients. Therefore, it is necessary to identify less toxic, inexpensive, novel and effective anti-angiogenic molecules. Several studies have indicated that natural plant products can meet these criteria. In this review, we discuss the anti-angiogenic properties of natural compounds isolated from plants and the molecular mechanisms by which these molecules act. Finally, we summarize the advantages of using plant products as anti-angiogenic agents. Compared with currently available anti-angiogenic drugs, plant products may not only have similar therapeutic potential but are also inexpensive, less toxic, and easy to administer. However, novel and effective strategies are necessary to improve their bioavailability for clinical use.
血管生成,即新血管形成,是多种疾病发病机制中的一个重要过程,因此已成为许多疾病预防和治疗的靶点。然而,目前使用的抗血管生成药物主要是合成化合物和人源化单克隆抗体,它们要么昂贵要么有毒,从而限制了它们在许多患者中的应用。因此,有必要鉴定毒性较小、价格低廉、新颖且有效的抗血管生成分子。多项研究表明,天然植物产物能够满足这些标准。在本综述中,我们讨论了从植物中分离出的天然化合物的抗血管生成特性以及这些分子发挥作用的分子机制。最后,我们总结了使用植物产物作为抗血管生成药物的优势。与目前可用的抗血管生成药物相比,植物产物不仅可能具有相似的治疗潜力,而且价格低廉、毒性较小且易于给药。然而,需要新颖有效的策略来提高它们在临床应用中的生物利用度。